Logo-jpd
Original

1. Effect and safety of alendronate on bone density in patients with chronic kidney disease; a controlled double blind randomized clinical trial
Heshmatollah Shahbazian, Mohammad-Reza Tamadon, Seyed Karim Mowla, Shokouh Shayanpour*, Fatemeh Hayati, Melika Shojaii, Leila Yazdanpanah
J Parathyr Dis. 2016;4(1): 3-6.
Article
PDF
XML
Cited By:
Review

2. Vitamin D and chronic kidney disease
 
Fatemeh Hayati, Mohammad Amin Nasouti*, Shokhouh Shayanpour, Shahla Ahmadi Halili, Hossain Karimpourian, Zarrin Beladi Mousavi
J Parathyr Dis. 2016;4(1): 25-30.
Article
PDF
XML
Cited By:
Original

3. Secondary hyperparathyroidism in chronic hemodialysis patients in Khuzestan province, Iran
 
Fatemeh Hayati, Seyed Seifollah Beladi Mousavi*, Mohammad Faramarzi
J Parathyr Dis. 2016;4(2): 43-47.
Article
PDF
XML
Cited By:
Commentary

4. Magnesium and parathyroid hormone among end-stage renal disease patients
Seyed Seifollah Beladi Mousavi, Fatemeh Hayati, Shokouh Shayanpour, Shahla Ahmadi Halili*
J Parathyr Dis. 2018;6(2): 72-73. doi: 10.15171/jpd.2018.22
Article
PDF
XML
Cited By:
1